Brazil Polymerase Chain Reaction Market Size & Outlook
Brazil polymerase chain reaction market, 2018-2030 (US$M)
Related Markets
Brazil polymerase chain reaction market highlights
- The Brazil polymerase chain reaction market generated a revenue of USD 180.3 million in 2023 and is expected to reach USD 206.8 million by 2030.
- The Brazil market is expected to grow at a CAGR of 2% from 2024 to 2030.
- In terms of segment, conventional pcr was the largest revenue generating type in 2023.
- Conventional PCR is the most lucrative type segment registering the fastest growth during the forecast period.
Polymerase chain reaction market data book summary
| Market revenue in 2023 | USD 180.3 million |
| Market revenue in 2030 | USD 206.8 million |
| Growth rate | 2% (CAGR from 2023 to 2030) |
| Largest segment | Conventional pcr |
| Fastest growing segment | Conventional PCR |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Conventional PCR |
| Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Abbott Laboratories, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Qiagen NV, Roche Holding AG ADR, Standard BioTools Inc, Stilla, Microsynth |
Other key industry trends
- In terms of revenue, Brazil accounted for 0.6% of the global polymerase chain reaction market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil polymerase chain reaction market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 206.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Polymerase Chain Reaction Market Scope
Polymerase Chain Reaction Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil polymerase chain reaction market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to polymerase chain reaction market will help companies and investors design strategic landscapes.
Conventional pcr was the largest segment with a revenue share of 13.7% in 2023. Horizon Databook has segmented the Brazil polymerase chain reaction market based on conventional pcr covering the revenue growth of each sub-segment from 2018 to 2030.
The Brazil PCR market accounted for the largest share in Latin America owing to increased funding and support for the biotechnology sector by the Government of Brazil (GOB) over the past few years. 46% of Brazilians are covered by private insurance companies.
High healthcare expenditure and the presence of the target population are major drivers of this market. In addition, awareness campaigns and premedical checkups are being conducted in Brazil by various nonprofit organizations to monitor the health status of people regularly.
Furthermore, demand for COVID-19 diagnostics increased, and flexible government regulations have supported the launch of diagnostics for COVID-19. As of May 2020, Brazil Health Regulatory Agency (ANVISA) allowed manufacturers to introduce their products with limited documents for six months.
Reasons to subscribe to Brazil polymerase chain reaction market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil polymerase chain reaction market databook
-
Our clientele includes a mix of polymerase chain reaction market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil polymerase chain reaction market , including forecasts for subscribers. This country databook contains high-level insights into Brazil polymerase chain reaction market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil polymerase chain reaction market size, by type, 2018-2030 (US$M)
Brazil Polymerase Chain Reaction Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
